International Oncology Network - Cancer & Hematology News

All Blog Posts Tagged 'Newly' (4)

Bevacizumab Receives Positive Opinion from Europe in Newly Diagnosed Advanced Ovarian Cancer

The European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the use of Bevacizumab (Avastin, Genentech/… Continue

Added by Peter Hofland, PhD on September 23, 2011 at 12:30am — No Comments

Zoledronic Acid Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients

Ongoing research has shown that bisphosphonates reduces the risk of skeletal events in patients with malignant bone disease. In preclinical models several bisphosphonates have also demonstrated anticancer activity. Among approved bisphosphonates, zoledronic acid (Zometa®, Novartis) has shown the highest potential anticancer effects in preclinical and clinical studies. New research has shown that regimen including zoledronic acid significantly improve both progression-free…

Continue

Added by Peter Hofland, PhD on December 4, 2010 at 4:00pm — No Comments

Dasatinib Receives Positive Opinion From The European Medicines Agency

Earlier today dasatinib (Sprycel®, Bristol-Myers Squibb) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive Chronic Myelogenous Leukaemia in Chronic Phase (CML-CP).

CML is a slow-growing type of leukemia in which the body produces an uncontrolled number of abnormal white blood cells. CML is most commonly diagnosed in those aged… Continue

Added by Peter Hofland, PhD on October 22, 2010 at 7:00am — No Comments

Bevacizumab May Delay Progression in Newly Diagnosed Ovarian Cancer

Early results from a large Phase-III trial suggest that adding bevacizumab (Avastin®, Genentech) to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment.

At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Tim… Continue

Added by Peter Hofland, PhD on October 11, 2010 at 6:30am — No Comments